Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001422848-25-000057
Filing Date
2025-04-04
Accepted
2025-04-04 16:24:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5645
  Complete submission text file 0001422848-25-000057.txt   7350
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 7818487100
HAEMONETICS CORP (Subject) CIK: 0000313143 (see all company filings)

EIN.: 042882273 | State of Incorp.: MA | Fiscal Year End: 0329
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-48277 | Film No.: 25815089
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071 213-486-9200
Capital Research Global Investors (Filed by) CIK: 0001422848 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A